as on October 25, 2025 at 1:29 am IST
Day's Low
Day's High
0.17%
Downside
2.53%
Upside
52 Week's Low
52 Week's High
49.61%
Downside
20.64%
Upside
Check Ocular Therapeutix Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.4B
EPS (TTM)
-1.4267
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-9.65
Industry PE ratio
-0.8798722044728434
PEG Ratio
0EBITDA
-237.3M
Revenue (TTM)
56.7M
Profit Margin
0.00%
Return On Equity TTM
-63.41%
Track how Ocular Therapeutix Inc P/E has moved over time to understand its valuation trends.
Ocular Therapeutix Inc in the last 5 years
Lowest (-86.29x)
December 31, 2021
Today (-9.65x)
October 25, 2025
Industry (-0.88x)
October 25, 2025
Highest (-2.53x)
December 31, 2023
Today’s Price to Earnings Ratio: -9.65x
Compare market cap, revenue, PE, and other key metrics of Ocular Therapeutix Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.4B | 12.87% | -9.65 | 0.00% | |
| BUY | $60.9B | 251.51% | -505.15 | -12.96% | |
| NA | $35.7B | NA | NA | -3.89% | |
| BUY | $109.3B | 99.16% | 30.04 | 31.86% | |
| BUY | $62.0B | -0.32% | 14.51 | 31.37% |
The Ocular Therapeutix Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Ocular Therapeutix Inc investment value today
Current value as on today
₹1,07,614
Returns
₹7,614
(+7.61%)
Returns from Ocular Therapeutix Inc Stock
₹3,052 (+3.05%)
Dollar Returns*
₹4,562 (+4.56%)
Based on 14 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Ocular Therapeutix Inc. Average target price of $21.92
Get share price movements and forecasts by analysts on Ocular Therapeutix Inc.
What analysts predicted
47.63%UPSIDE
Target Price
$21.92
Current Price
$11.48
Analyzed by
14 Analysts
Target
$21.92
Ocular Therapeutix Inc target price $21.92, a slight upside of 47.63% compared to current price of $11.48. According to 14 analysts rating.
Search interest for Ocular Therapeutix Inc Stock has increased by 663% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:663% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 02 October
Thu, 10:16 AM
-Ocular Therapeutix shares drop 6.7% after announcing $475 million share sale to fund clinical trials and infrastructure.
Thu, 03:22 PM
-Analyst reiterates Buy rating for Ocular Therapeutix, citing promising clinical trials and strategic advancements.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 10.63M → 13.45M (in $), with an average increase of 21.0% per quarter
Best in 3 Years
![]()
In the last 3 years, OCUL has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 3 years, OCUL stock has moved up by 212.2%
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.7% return, outperforming this stock by 59.6%
Profit Down
![]()
Netprofit is down for the last 4 quarters, -36.49M → -67.81M (in $), with an average decrease of 23.6% per quarter
| Organisation | Ocular Therapeutix Inc |
| Headquarters | 15 Crosby Drive, Bedford, MA, United States, 01730 |
| Industry | Health Technology |
| CEO | Dr. Pravin U. Dugel M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Donald Notman Jr. | CFO, COO & Principal Accounting Officer |
Dr. Peter K. Jarrett Ph.D. | Chief Technical Officer |
Mr. Todd D.C. Anderman J.D. | Chief Legal Officer & Corporate Secretary |
Mr. William S. Slattery Jr. | Vice President of Investor Relations |
Mr. William H. Ransone II | Vice President of Global Sales & Marketing |
Mr. Barry Rubenstein M.S. | Chief Human Resources Officer |
Mr. Steve Meyers | Chief Commercial Officer |
Dr. Pravin U. Dugel M.D. | Executive Chairman, President & CEO |
Dr. Jeffrey S. Heier M.D. | Chief Scientific Officer |
Dr. Peter K. Kaiser M.D. | Chief Development Officer |
Ocular Therapeutix Inc share price today is $11.48 as on at the close of the market. Ocular Therapeutix Inc share today touched a day high of $11.77 and a low of $11.46.
Ocular Therapeutix Inc share touched a 52 week high of $13.85 on and a 52 week low of $5.79 on . Ocular Therapeutix Inc stock price today i.e. is closed at $11.48,which is 17.11% down from its 52 week high and 98.44% up from its 52 week low.
Ocular Therapeutix Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Ocular Therapeutix Inc (OCUL) shares with as little as ₹87.759 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹877.59 in Ocular Therapeutix Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Ocular Therapeutix Inc share’s latest price of $11.48 as on October 25, 2025 at 1:29 am IST, you will get 0.8711 shares of Ocular Therapeutix Inc. Learn more about
fractional shares .
Ocular Therapeutix Inc stock has given 12.87% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?